Ocean Biomedical (NASDAQ: OCEA) Will Target Pulmonary Fibros

Ocean Biomedical (NASDAQ: OCEA) Will Target Pulmonary Fibrosis Discoveries as Novel Treatments of Hermansky-Pudlak Syndrome

Ocean Biomedical (NASDAQ: OCEA) Will Target Pulmonary Fibrosis Discoveries as Novel Treatments of Hermansky-Pudlak Syndrome
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Puerto Rico , United States , Suren Ajjarapu , Jacka Elias , Chirinjeev Kathuria , Kevin Kertscher , Critical Care Medicine At Yale University , Brown University , Ocean Biomedical Inc , Company On , Company Annual Report On Form , Nasdaq , Communications Director , Hermansky Pudlak Syndrome , Awareness Day , Ocean Biomedical , Scientific Co Founder , Idiopathic Pulmonary Fibrosis , Critical Care Medicine , Yale University , Yale New Haven , Pudlak Syndrome , Orphan Drug Act , Rhode Island Based , Annual Report ,